(Q81914008)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

chronic schizophrenia

1 reference

Takefumi Suzuki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Hiroyuki Uchida

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Hiroyoshi Takeuchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Kensuke Nomura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Akira Tanabe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Koichiro Watanabe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Gohei Yagi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Haruo Kashima

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

566-575

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15991004%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00213-005-0018-3

13 January 2020

exact match

0 references

cites work

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

1 reference

12 December 2020

Interventions to improve medication adherence in schizophrenia

1 reference

12 December 2020

A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol

1 reference

12 December 2020

Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophrenia

1 reference

12 December 2020

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.

1 reference

12 December 2020

Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.

1 reference

12 December 2020

Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.

1 reference

12 December 2020

Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.

1 reference

12 December 2020

A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients

1 reference

12 December 2020

Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics

1 reference

12 December 2020

Predictors of noncompliance in patients with schizophrenia.

1 reference

12 December 2020

Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS.

1 reference

12 December 2020

Issues of adherence to immunosuppressant therapy after solid-organ transplantation

1 reference

12 December 2020

Optimal drug and behavior therapy for treatment-refractory schizophrenic patients

1 reference

12 December 2020

Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.

1 reference

12 December 2020

Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses

1 reference

12 December 2020

A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study

1 reference

12 December 2020

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

1 reference

12 December 2020

An investigation of ethnic and gender differences in the pharmacodynamics of haloperidol

1 reference

12 December 2020

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

1 reference

12 December 2020

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

1 reference

12 December 2020

A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia

1 reference

12 December 2020

Significant dissociation of brain and plasma kinetics with antipsychotics

1 reference

12 December 2020

The current status of tardive dyskinesia.

1 reference

12 December 2020

Compliance therapy: a randomised controlled trial in schizophrenia

1 reference

12 December 2020

Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis

1 reference

12 December 2020

The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen.

1 reference

12 December 2020

Adherence to conventional and atypical antipsychotics after hospital discharge.

1 reference

12 December 2020

A controlled dose comparison of haloperidol in newly admitted schizophrenic patients

1 reference

12 December 2020

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update

1 reference

12 December 2020

Haloperidol half-life after chronic dosing

1 reference

12 December 2020

The impact of reducing dose frequency on health outcomes

1 reference

12 December 2020

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis

1 reference

12 December 2020

A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Dosing Regimen Effects of Modafinil for Improving Daytime Wakefulness in Patients With Narcolepsy

1 reference

12 December 2020

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

12 December 2020

Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study

1 reference

12 December 2020

Optimal haloperidol dosage in first-episode psychosis.

1 reference

12 December 2020

Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy.

1 reference

12 December 2020

A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation

1 reference

12 December 2020

Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia

1 reference

12 December 2020

A Pharmacokinetic/Pharmacodynamic Study Comparing a Single Morning Dose of Adderall to Twice-Daily Dosing in Children With ADHD

1 reference

12 December 2020

Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics

1 reference

12 December 2020

Haloperidol blood levels and clinical effects

1 reference

12 December 2020

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature

1 reference

12 December 2020

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia

1 reference

12 December 2020